Medipost Co (Medipost Co) FCF Margin % : -32.53% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Medipost Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Medipost Co's Free Cash Flow for the three months ended in Mar. 2024 was $-4.40 Mil. Medipost Co's Revenue for the three months ended in Mar. 2024 was $13.54 Mil. Therefore, Medipost Co's FCF Margin % for the quarter that ended in Mar. 2024 was -32.53%.

As of today, Medipost Co's current FCF Yield % is -9.97%.

The historical rank and industry rank for Medipost Co's FCF Margin % or its related term are showing as below:

MEPTF' s FCF Margin % Range Over the Past 10 Years
Min: -79.37 Med: -16.57 Max: 11.22
Current: -32.91

During the past 13 years, the highest FCF Margin % of Medipost Co was 11.22%. The lowest was -79.37%. And the median was -16.57%.

MEPTF's FCF Margin % is ranked better than
64.71% of 1040 companies
in the Biotechnology industry
Industry Median: -139.2 vs MEPTF: -32.91

Medipost Co FCF Margin % Historical Data

The historical data trend for Medipost Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co FCF Margin % Chart

Medipost Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

11.22

4.73

-12.91

-12.12

-13.87

Medipost Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-27.68	-33.37	-20.20	-45.55	-32.53

Competitive Comparison of Medipost Co's FCF Margin %

For the Biotechnology subindustry, Medipost Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medipost Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medipost Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Medipost Co's FCF Margin % falls into.

Medipost Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Medipost Co's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-6.885	/	49.631
	=	-13.87 %

Medipost Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-4.404	/	13.54
	=	-32.53 %

Medipost Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Medipost Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medipost Co (Medipost Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (OTCPK:MEPTF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

078160:Korea

Address

21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR

Website

http://www.medi-post.co.kr

Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (Medipost Co) Headlines

No Headlines